{ "cik": 1398733, "cik_padded": "0001398733", "entityName": "Aquestive Therapeutics, Inc.", "fiscal_years": [ { "accn": "0001398733-26-000018", "filed": "2026-03-04", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 562000.0, "eps_diluted": -0.78, "free_cash_flow": -52994000.0, "net_income": -83784000.0, "operating_cash_flow": -52432000.0, "operating_income": -71051000.0, "revenue": 44545000.0, "stockholders_equity": -33662000.0, "total_assets": 160425000.0, "total_liabilities": 194087000.0 }, "period_end": "2025-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": -0.22612532791299664, "roa_avg2y": -0.6399413402380761, "roa_period_end": -0.522262739597943, "roe_avg2y": 1.7860964846831098 } }, { "accn": "0001398733-26-000018", "filed": "2026-03-04", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 159000.0, "eps_diluted": -0.51, "free_cash_flow": -35918000.0, "net_income": -44137000.0, "operating_cash_flow": -35759000.0, "operating_income": -30771000.0, "revenue": 57561000.0, "stockholders_equity": -60156000.0, "total_assets": 101424000.0, "total_liabilities": 161580000.0 }, "period_end": "2024-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -0.7667865394972292, "operating_margin": -0.5345807056861417, "revenue_growth_yoy": 0.1379514856770061, "roa_avg2y": -0.5557346293801387, "roa_period_end": -0.4351731345638113, "roe_avg2y": 0.5297192201292583 } }, { "accn": "0001398733-26-000018", "filed": "2026-03-04", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 995000.0, "eps_diluted": -0.13, "free_cash_flow": -7375000.0, "net_income": -7870000.0, "operating_cash_flow": -6380000.0, "operating_income": -15102000.0, "revenue": 50583000.0, "stockholders_equity": -106487000.0, "total_assets": 57418000.0, "total_liabilities": 163905000.0 }, "period_end": "2023-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -0.15558586877014016, "operating_margin": -0.2985588043413795, "revenue_growth_yoy": 0.06088506711409396, "roa_avg2y": -0.13748165746628468, "roa_period_end": -0.13706503187153854, "roe_avg2y": 0.06994281042121213 } }, { "accn": "0001628280-25-010506", "filed": "2025-03-05", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1024000.0, "eps_diluted": -1.12, "free_cash_flow": -10843000.0, "net_income": -54410000.0, "operating_cash_flow": -9819000.0, "operating_income": -42066000.0, "revenue": 47680000.0, "stockholders_equity": -118554000.0, "total_assets": 57070000.0, "total_liabilities": 175624000.0 }, "period_end": "2022-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -1.1411493288590604, "operating_margin": -0.882256711409396, "revenue_growth_yoy": -0.06200818382121498, "roa_avg2y": -0.9139699150869708, "roa_period_end": -0.9533905729805503, "roe_avg2y": 0.5422347125886949 } }, { "accn": "0001628280-24-009010", "filed": "2024-03-05", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 913000.0, "eps_diluted": -1.85, "free_cash_flow": -33892000.0, "net_income": -70539000.0, "operating_cash_flow": -32979000.0, "operating_income": -34679000.0, "revenue": 50832000.0, "stockholders_equity": -82134000.0, "total_assets": 61993000.0, "total_liabilities": 144127000.0 }, "period_end": "2021-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -1.3876888574126534, "operating_margin": -0.6822277305634246, "revenue_growth_yoy": 0.10868285022574102, "roa_avg2y": -1.1297356598893311, "roa_period_end": -1.1378542738696305, "roe_avg2y": 1.0799733600753267 } }, { "accn": "0001628280-23-010180", "filed": "2023-03-31", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 517000.0, "eps_diluted": -1.66, "free_cash_flow": -45976000.0, "net_income": -55783000.0, "operating_cash_flow": -45459000.0, "operating_income": -42893000.0, "revenue": 45849000.0, "stockholders_equity": -48497000.0, "total_assets": 62884000.0, "total_liabilities": 111381000.0 }, "period_end": "2020-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -1.2166677572029925, "operating_margin": -0.9355274924207726, "revenue_growth_yoy": -0.1284951244083712, "roa_avg2y": -0.7892164144790362, "roa_period_end": -0.8870777940334584, "roe_avg2y": 2.0426225306212125 } }, { "accn": "0001628280-22-005393", "filed": "2022-03-08", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 663000.0, "free_cash_flow": -60873000.0, "net_income": -66246000.0, "operating_cash_flow": -60210000.0, "operating_income": -52668000.0, "revenue": 52609000.0, "stockholders_equity": -6122000.0, "total_assets": 78479000.0, "total_liabilities": 84601000.0 }, "period_end": "2019-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -1.259214202893041, "operating_margin": -1.0011214811153986, "revenue_growth_yoy": -0.21979830935785258, "roa_avg2y": -0.8013790600616948, "roa_period_end": -0.8441239057582283, "roe_avg2y": -33.474482061647294 } }, { "accn": "0001140361-21-007811", "filed": "2021-03-09", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1824000.0, "free_cash_flow": -14815000.0, "net_income": -61376000.0, "operating_cash_flow": -12991000.0, "operating_income": -48934000.0, "revenue": 67430000.0, "stockholders_equity": 10080000.0, "total_assets": 86851000.0, "total_liabilities": 76771000.0 }, "period_end": "2018-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -0.9102180038558505, "operating_margin": -0.7257007266795195, "roa_avg2y": -0.9444859079612516, "roa_period_end": -0.7066815580707189, "roe_avg2y": 7.478038379530917 } }, { "accn": "0001140361-20-005499", "filed": "2020-03-11", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2068000.0, "free_cash_flow": 3756000.0, "net_income": -8943000.0, "operating_cash_flow": 5824000.0, "operating_income": -113000.0, "stockholders_equity": -26495000.0, "total_assets": 43116000.0, "total_liabilities": 69611000.0 }, "period_end": "2017-12-31", "ratio_units": { "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_period_end": -0.20741720011132758, "roe_avg2y": 0.21371218276537782 } }, { "accn": "0001140361-19-004934", "filed": "2019-03-14", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": -57197000.0 }, "period_end": "2016-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001398733-26-000018", "filed": "2026-03-04", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001398733.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001398733.json" }, "ticker": "AQST" }